Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Diagnostic Substances Sector (CIX: MSECTOR516)
2,109.14   -6.37 (-0.30%)
Streaming Delayed Price  /  Updated: 3:45 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Sector News
Stories about Diagnostic Substances Sector
 
< Previous 1 2 3 Next >
Investing in Cancer Research Is Worth the Risk: Echo He
May 23, 2013
Source: George S. Mack of The Life Sciences Report (5/23/13) http://www.thelifesciencesreport.com/pub/na/15301 If investigators could find a way to make breast cancer survivors truly cancer free, and... Read More
category RHHBY , INFI , CELG , and 5 more.
from Bio-Wire.Com
Commit To Buy Synta Pharmaceuticals Corp At $5, Earn 97.3% Annualized
May 23, 2013
Investors considering a purchase of Synta Pharmaceuticals Corp (SNTA) shares, but cautious about paying the going market price of $7.44/share, might benefit from considering selling puts among the... Read More
category Stocks
from Market News Video
Commit To Buy Synta Pharmaceuticals Corp At $5, Earn 97.3% Annualized
May 23, 2013
Investors considering a purchase of Synta Pharmaceuticals Corp (SNTA) shares, but cautious about paying the going market price of $7.44/share, might benefit from considering selling puts among the... Read More
category Dividends
from Dividend Channel
Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized
May 23, 2013
Investors considering a purchase of Immunomedics, Inc. (IMMU) shares, but cautious about paying the going market price of $3.27/share, might benefit from considering selling puts among the alternative... Read More
category Stocks
from Market News Video
Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized
May 23, 2013
Investors considering a purchase of Immunomedics, Inc. (IMMU) shares, but cautious about paying the going market price of $3.27/share, might benefit from considering selling puts among the alternative... Read More
category Dividends
from Dividend Channel
The Early Movers – who’s hot, who’s not
May 23, 2013
Which RegMed companies are making moves in the 1st hour Signs of life … Wright-Medical (WMGI +$0.17) and  Reneuron (LON:RENE +$0.16) are the leaders as today’s market opens… …followed by Harvard Bio... Read More
category Henry McCusker
from Bio-Wire.Com
33.5% Return Seen to Date on SmarTrend Infinity Pharmaceuticals Call (INFI)
May 23, 2013
from Comtex SmarTrend® News Briefs
OncoGenex Plans Cedar Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer
May 23, 2013
OncoGenex Pharmaceuticals (NASDAQ: OGXI ) today announced plans for the initiation of the Cedar™ clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in... Read More
category Benzinga , Global , Guidance , and 2 more.
from Latest Articles from Benzinga.com
Bio-Wire Equity Surveillance – Closing Bell 5/22/2013
May 22, 2013
Notable Jumps by % Gain / Mkt Cap Change MannKind Corporation (NASDAQ: MNKD) +16.2 after Piper Jaffray analyst Ian Somaiya estimates a potential valuation of the company in the $3-4B range in the event... Read More
category Bio/Wire
from Bio-Wire.Com
Market Wrap for Wednesday, May 22: Stocks Pullback As Bernanke Says Bond Buying Could Slow
May 22, 2013
In Congressional testimony on Wednesday, Federal Reserve Chairman Ben Bernanke said that the central bank could begin winding down its $85 billion-per-month bond-buying program at one of its "next few... Read More
category Earnings , BAH , Benzinga , and 29 more.
from Latest Articles from Benzinga.com
Myriad Genetics (MYGN) Dips Mid-Day
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8362311 for the full story. Read More
from StreetInsider.com News Articles
AMAG Pharma (AMAG) Declines After Recalling Batch of Rienso
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8362197 for the full story. Read More
from StreetInsider.com News Articles
Celldex Therapeutics Bullish Moving Average Crossover Alert (CLDX)
May 22, 2013
from Comtex SmarTrend® News Briefs
The Early Movers – who’s hot, who’s not
May 22, 2013
Which RegMed companies are making moves in the 1st hour?    Signs of life … Shire ADR (SHPG +$0.35) and Wright-Medical (WMGI +$0.19) are the leaders as today’s market opens… …followed by MiMedx (MDXG... Read More
category Henry McCusker
from Bio-Wire.Com
6 Biotechnology Stocks to Buy Now
May 22, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 4 more.
from InvestorPlace - Latest Headlines
The Curious Case Of Human Gene Patents
May 22, 2013
Critics who think the U.S. Patent Office has been too liberal in awarding protection for naturally occurring phenomena like human genes are watching Association for Molecular Pathology v. Myriad... Read More
category NASDAQ:MYGN
from Forbes Real Time
CORRECTED-Amag investigates anemia drug after report of death in Switzerland
May 21, 2013
(Corrects headline to "investigates." Amag did not say the drug caused the fatality.) Read More
category companyNews
from Reuters: Company News
Charting a persistent May uptrend
May 21, 2013
The major U.S. stock benchmarks have knifed to less-charted territory, and the technical price action is holding true to form. Read More
category Retail , Opinion , MYGN , and 16 more.
from MarketWatch
The Early Movers – who’s hot, who’s not
May 21, 2013
Which RegMed companies are making moves in the 1st hour?Signs of life … Shire ADR (SHPG +$0.90) and are the leaders as today’s market opens… …followed by Osiris (OSIR +$0.14) ReNeuron (LON: RENE... Read More
category Henry McCusker
from Bio-Wire.Com
AMAG July Options Begin Trading
May 20, 2013
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options become available today, for the July expiration. Read More
category Stocks
from Market News Video
The Early Movers – who’s hot, who’s not
May 20, 2013
Which RegMed companies are making moves in the 1st hour? Signs of life … Shire ADR (SHPG +$1.43) and Stemline (STML +$0.24) are the leaders as today’s market opens… …followed by Wright-Medical (WMGI... Read More
category Henry McCusker
from Bio-Wire.Com
Post Earnings Update: Akorn Has Climbed 3.4% Higher in Past Week (AKRX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Celldex Therapeutics Earnings Review: 18 Days after Announcement Shares Up 1.8% (CLDX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Synta Pharmaceuticals Earnings Review: 20 Days after Announcement Shares Down 26.8% (SNTA)
May 20, 2013
from Comtex SmarTrend® News Briefs
The Best- And Worst- Performing Biotech Stocks, May 10 To May 17
May 19, 2013
These are the best and worst-performing medical and biotech stocks from May 10 to May 17, 2013. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the... Read More
category NASDAQ:MAKO , NASDAQ:PBYI , NASDAQ:INFI , and 2 more.
from Forbes Real Time
HALO, NTAP, INFI and DRYS added to Nasdaq Active Stock Watch List at EPR
May 17, 2013
from ACCESSWIRE
The Early Movers – who’s hot, who’s not
May 17, 2013
Which RegMed companies are making moves in the 1st hour Signs of life … Stemline (STML +$0.70) and Wright-Medical (WMGI +$0.24) are the leaders as today’s market opens… …followed by Neuralstem... Read More
category Henry McCusker
from Bio-Wire.Com
Infinity To Present Data
May 16, 2013
Infinity Pharmaceuticals Inc. (Nasdaq: INFI) will present clinical trial data for its IPI-145 at two upcoming conferences. The stock price plummeted $7.12 to close at $24.32.... Read More
from MarketMinute.com Stock News
Market Wrap for Thursday, May 16: A Small Pullback For U.S. Stocks as Economic Data Disappoints
May 16, 2013
Stocks pulled back late on Thursday as bullish sentiment could not overcome disappointing economic reports. Initial jobless claims, housing starts and a reading of the Philadelphia Fed's Business... Read More
category Earnings , Benzinga , Movers , and 27 more.
from Latest Articles from Benzinga.com
Mid-Afternoon Market Update: Optimer Falls as Halozyme Rockets Upwards
May 16, 2013
Toward the end of trading Thursday, the Dow was down 0.10 percent to 15,259.91, while the NASDAQ rose 0.13 percent to 3,476.15. The S&P traded down, falling 0.23 percent to 1,654.47. Top Headline US... Read More
category Earnings , HALO , Benzinga , and 17 more.
from Latest Articles from Benzinga.com
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here